1. Home
  2. JFIN vs ORMP Comparison

JFIN vs ORMP Comparison

Compare JFIN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JFIN

Jiayin Group Inc.

HOLD

Current Price

$2.86

Market Cap

149.7M

Sector

Finance

ML Signal

HOLD

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.60

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFIN
ORMP
Founded
2011
2002
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.7M
165.3M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
JFIN
ORMP
Price
$2.86
$4.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
97.5K
470.5K
Earning Date
06-03-2026
05-14-2026
Dividend Yield
17.47%
6.51%
EPS Growth
N/A
412.50
EPS
N/A
0.91
Revenue
N/A
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.35
$5.05
Revenue Growth
N/A
49.25
52 Week Low
$2.70
$1.98
52 Week High
$18.70
$5.19

Technical Indicators

Market Signals
Indicator
JFIN
ORMP
Relative Strength Index (RSI) 30.03 60.43
Support Level $2.70 $3.69
Resistance Level $4.45 $5.10
Average True Range (ATR) 0.29 0.32
MACD -0.06 0.08
Stochastic Oscillator 9.97 58.74

Price Performance

Historical Comparison
JFIN
ORMP

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Share on Social Networks: